Holen Sie sich die Stockscreener-App
183.78
0.80%
-1.49
Schlusskurs vom Vortag:
$185.27
Offen:
$182.08
24-Stunden-Volumen:
1.07M
Relative Volume:
1.21
Marktkapitalisierung:
$14.18B
Einnahmen:
$8.27B
Nettoeinkommen (Verlust:
$173.28M
KGV:
84.64
EPS:
2.1712
Netto-Cashflow:
$785.90M
1W Leistung:
+5.51%
1M Leistung:
+6.64%
6M Leistung:
+78.06%
1J Leistung:
+0.96%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$171.54
$190.56
52-Wochen-Spanne:
$66.57
$203.91
Icon Plc Stock (ICLR) Company Profile
Firmenname
Icon Plc
Sektor
Branche
Telefon
-
Adresse
-
Compare ICLR vs TMO, DHR, NTRA, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
183.78 | 14.18B | 8.27B | 173.28M | 785.90M | 2.1712 |
TMO
Thermo Fisher Scientific Inc
|
684.89 | 253.24B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.97 | 163.77B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
404.90 | 58.36B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
175.96 | 49.61B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
273.60 | 45.03B | 16.63B | 1.39B | 2.12B | 8.0674 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-09-30 | Fortgesetzt | UBS | Neutral |
| 2026-06-30 | Hochstufung | Truist | Hold → Buy |
| 2026-06-25 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2026-05-18 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2026-03-26 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2026-02-23 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-18 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-17 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2026-01-08 | Herabstufung | Truist | Buy → Hold |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-09-09 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-03 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-21 | Herabstufung | Goldman | Buy → Neutral |
| 2025-01-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-09-18 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2023-12-15 | Eingeleitet | Truist | Buy |
| 2023-09-13 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-09-07 | Eingeleitet | UBS | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-14 | Eingeleitet | Citigroup | Neutral |
| 2021-04-13 | Fortgesetzt | BofA Securities | Neutral |
| 2021-04-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Equal Weight |
| 2021-03-01 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-26 | Hochstufung | Truist | Hold → Buy |
| 2020-07-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-04-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Hold |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2018-10-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Eingeleitet | UBS | Sell |
| 2018-04-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Bestätigt | Mizuho | Neutral |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-10-27 | Bestätigt | Barclays | Equal Weight |
| 2017-09-11 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-31 | Hochstufung | SunTrust | Hold → Buy |
| 2017-07-27 | Bestätigt | Mizuho | Neutral |
| 2017-06-29 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Icon Plc Aktie (ICLR) Neueste Nachrichten
Form 4 ICON PLC: Emer Lyons (Chief Accounting Officer) For: 22 October - Investing.com Nigeria
To cover taxes, ICON (ICLR) accounting chief sells 272 shares after 510-share vesting. - Stock Titan
ICON plc (ICLR) Stock forecasts - Yahoo Finance UK
ICON PLC expected to post earnings of $2.60 a shareEarnings Preview - TradingView
ICON plc (ICLR) Stock forecasts - Yahoo Finance Singapore
Analysts Estimate Alignment Healthcare (ALHC) to Report a Decline in Earnings: What to Look Out for - Zacks Investment Research
ICON Public Limited Company (ICLR) Stock Price, News, Quote & History - Yahoo! Finance Canada
ICON plc (ICLR) Stock Forecasts - Yahoo Finance
Earnings Preview: Icon PLC to Report Financial Results Post-market on October 27 - Moomoo
A Look at Icon PLC (ICLR) After 6.3% Gain -- GF Value $205.34 vs Price $185.25 - GuruFocus
ICON Plc (ICLR) Rises as Investors Look Ahead to Late-October Earnings, Though a Single Clear Catalyst Is Not Obvious - Moomoo
ICON plc (ICLR) rises as investors look ahead to late-October earnings, though a single clear catalyst is not obvious - Quiver Quantitative
UBS Maintains Icon PLC(ICLR.US) With Hold Rating, Maintains Target Price $195 - Moomoo
A Look at Icon PLC (ICLR) After 3.6% Gain -- GF Value $205.38 vs Price $174.19 - GuruFocus
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Icon PLC (ICLR) Shares Surge 3.6% -- What GF Score of 94 Tells I - GuruFocus
ICON plc Stock 12‑Month Price Target Cut to $188.56, Implies 12% Upside - TradingView
Patrick Nadolny Appointed Senior Vice President, Biometrics at ICON plc - https://hrtoday.in/
RBC Capital Keeps Their Buy Rating on Icon (ICLR) - The Globe and Mail
RBC Capital Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $185 - Moomoo
BofA Securities Upgrades Icon PLC (ICLR) to Neutral, Lifts Price Target Amid Positive CRO Outlook - GuruFocus
ICON plc Stock 12‑Month Price Target Raised to $187.81, Implies 14% Upside - TradingView
Results arrive after market close October 27 for ICON (ICLR), with an earnings call October 28. - Stock Titan
ICON Schedules Third Quarter 2026 Earnings Conference Call - Business Wire
ICON Schedules Third Quarter 2026 Earnings Conference Call - Yahoo Finance
RBC Capital Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $185 - Moomoo
Is Icon PLC (ICLR) a Bargain After 3.9% Drop? GF Value Says Unde - GuruFocus
Is It Too Late to Buy Icon PLC (ICLR) After 3.9% Rally? GF Value Says Undervalued - GuruFocus
UBS Maintains Icon PLC(ICLR.US) With Hold Rating, Maintains Target Price $195 - Moomoo
Q4 2025 ICON PLC Earnings Call Transcript - gurufocus.com
Icon PLC (ICLR) Stock Down 4.8% -- Now Undervalued? GF Score: 94/100 - gurufocus.com
UBS Restarts Coverage of Icon PLC (ICLR) with Neutral Rating and $195 Price Target - gurufocus.com
A Look at Icon PLC (ICLR) After 6.1% Gain -- GF Value $205.79 vs Price $173.90 - GuruFocus
ICON Plc (ICLR) Rises as Investors Appear to Lean on Backlog, Guidance, and Recent Filings - Moomoo
ICON plc (ICLR) rises as investors appear to lean on backlog, guidance, and recent filings - Quiver Quantitative
ICON Public Limited Company’s (ICLR) Shrinking Moat Warranted an Early Departure - Currently.com
ICON Public Limited Company’s (ICLR) Shrinking Moat Warranted an Early Departure - Yahoo Finance Singapore
Hybrid Clinical Research Associate Job at ICON | Apply Online Here - BioTecNika
Icon PLC (ICLR) Stock Up 3.3% and Still Undervalued -- GF Score: 95/100 - GuruFocus
Rare Disease Contract Research Organization (CRO) Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook - GlobeNewswire Inc.
Icon PLC (ICLR) Stock Down 3.3% -- Now Undervalued? GF Score: 96/100 - GuruFocus
ICON PLC Director Eugene McCague Exercises Stock Options and Sells Shares on September 17, 2026 - Kalkine Media
Citi Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $175 - Moomoo
S&P 500 Futures Rise in Premarket Trading; Xenon Pharmaceuticals, Icon PLC Lag - barrons.com
Icon (ICLR) insider sells 5,005 shares after exercising options - Stock Titan
Director at ICON (ICLR) unloads stock right after exercising options - Stock Titan
Director at ICON (NASDAQ: ICLR) exercises options, then sells 5,005 shares - Stock Titan
Icon (ICLR) Stock Forecast and Price Target 2026 $ICLR - MarketBeat
ICON PLC (NASDAQ: ICLR) director plans 569,625 stock sale - Stock Titan
ICON (NASDAQ: ICLR) director plans to sell thousands of shares in 2026 - Stock Titan
Finanzdaten der Icon Plc-Aktie (ICLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Icon Plc-Aktie (ICLR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Murphy Ronan Martin | Director |
Sep 17 '26 |
Sale |
175.00 |
5,005 |
875,875 |
3,847 |
| EUGENE PACELLI MCCAGUE | Director |
Sep 17 '26 |
Proposed Sale |
175.00 |
3,255 |
569,625 |
0 |
| RONAN MARTIN MURPHY | Director |
Sep 17 '26 |
Proposed Sale |
175.00 |
5,005 |
875,875 |
0 |
| McCague Eugene Pacelli | Director |
Sep 17 '26 |
Sale |
175.00 |
3,255 |
569,625 |
3,811 |
| McCague Eugene Pacelli | Director |
Sep 17 '26 |
Option Exercise |
125.74 |
3,255 |
409,284 |
7,066 |
| Murphy Ronan Martin | Director |
Sep 17 '26 |
Option Exercise |
125.74 |
5,005 |
629,329 |
8,852 |
| CLIMAX JOHN DR | Director |
Sep 16 '26 |
Sale |
175.00 |
5,005 |
875,875 |
2,087 |
| JOHN CLIMAX | Director |
Sep 16 '26 |
Proposed Sale |
175.00 |
5,005 |
875,875 |
0 |
| CLIMAX JOHN DR | Director |
Sep 16 '26 |
Option Exercise |
125.74 |
5,005 |
629,329 |
7,092 |
| LINDA SUE GRAIS | Director |
Aug 11 '26 |
Proposed Sale |
164.29 |
841 |
138,170 |
0 |
3.45%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):